Connect Biopharma Holdings Limited (NASDAQ:CNTB – Get Rating) was the recipient of a significant growth in short interest during the month of March. As of March 31st, there was short interest totalling 150,000 shares, a growth of 100.8% from the March 15th total of 74,700 shares. Approximately 0.3% of the shares of the stock are […]
CDE’s Pre-NDA Feedback Confirms CBP-201 for Atopic Dermatitis on Track for NDA Submission in China by End of First Quarter 2024 SAN DIEGO and TAICANG, SUZHOU, China, April 11, 2023 . | April 11, 2023
CDE’s Pre-NDA Feedback Confirms CBP-201 for Atopic Dermatitis on Track for NDA Submission in China by End of First Quarter 2024 SAN DIEGO and TAICANG,.
CDE’s Pre-NDA Feedback Confirms CBP-201 for Atopic Dermatitis on Track for NDA Submission in China by End of First Quarter 2024 SAN DIEGO and TAICANG, SUZHOU, China, April 11, 2023. | June 20, 2023